Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients

Chest

Volumn 114, Issue 2, 1998, Pages 495-499

  Niimi, Takashi ^a   Tomita, Hiroshi ^a   Sato, Shigeki ^a   Mori, Toshiyuki ^a   Kawaguchi, Haruhiko ^a   Sugiura, Yoshiki ^a   Matsuda, Ryohei ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin converting enzyme; Bradykinin; Bronchial responsiveness; Gene; Polymorphism; Sarcoidosis; Tachykinin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AIRWAY REACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0031813389     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.2.495     Document Type: Article

References (30)

1. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135: 747-60
2. Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur Respir J 1994; 7:624-27
3. Studdy RP, James DG. The specificity and sensitivity of serum angiotensin converting enzyme in sarcoidosis and other disease. Experience in twelve centers in six different countries. In: Chretien J, ed. Sarcoidosis and other granulomatous disorders. Paris: Pergamon, 1983; 332-44
4. Rigat B, Huber C, Gelas FA, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-46
5. Hubert C, Houot AM, Corvol P, et al. Structure of the angiotensin I-converting enzyme gene. J Biol Chem 1991; 266:15377-383
6. Tomita H, Ina Y, Sugiura Y, et al. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis. Am J Respir Crit Care Med 1997; 156:255-59
7. Barnes PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991; 144:1187-98
8. Ichinose M, Barnes PJ. The effect of peptidase inhibitors on bradykinin-induced bronchoconstriction in guinea-pigs in vivo. Br J Pharmacol 1990; 101:77-80
9. Barnes PJ. Asthma as an axon reflex. Lancet 1986; 1(8475): 242-45
10. Nadel JA. Neurogenic inflammation in airways and its modulation by peptidases. Ann NY Acad Sci 1992; 664:408-14
11. Kaufman J, Schmitt S, Barnard J, et al. Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma. Chest 1992; 101:922-25
12. Semple PF, Herd GW. Cough and wheeze caused by inhibitors of angiotensin-converting enzyme [letter]. N Engl J Med 1986; 314:61
13. Furuya K, Yamaguchi E, Hirabayashi T, et al. Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough [letter]. Lancet 1994; 343:354
14. Alyn HM, Andrew JT, Kate L. Human ACE gene polymorphism and distilled water induced cough. Thorax 1997; 52:111-13
15. Laitinen LA, Haahtela T, Kava T, et al. Non-specific bronchial reactivity and ultrastructure of the airway epithelium in patients with sarcoidosis and allergic alveolitis. Eur J Respir Dis Suppl 1983; 131:267-84
16. Olafsson M, Simonsson BG, Hansson SB. Bronchial reactivity in patients with recent pulmonary sarcoidosis. Thorax 1985; 40:51-53
17. Shima K, Takenaka S, Fukuda K, et al. Bronchial hyperreactivity in sarcoidosis. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Amsterdam: Elsevier, 1988; 355-60
18. Silvano M, Marcello AL, Roberto P, et al. Aspecific bronchial hyperreactivity in pulmonary sarcoidosis. Sarcoidosis 1994; 11:118-22
19. Ohrn MB, Skold CM, van Hage-Hamsten M, et al. Sarcoidosis patients have bronchial hyperreactivity and signs of mast cell activation in their bronchoalveolar lavage. Respiration 1995; 62:136-42
20. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-44
21. Takishima T, Hida W, Sasaki H, et al. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981; 80:600-06
22. Ishii M, Hida W, Suzuki S, et al. Comparison of intermittent and continuous inhalation provocation tests. Ann Allergy 1989; 62:223-28
23. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239:487-91
24. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene. Nucleic Acids Res 1992; 20:1433
25. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332:706-11
26. Kasahara Y, Ashihara Y. Colorimetry of angiotensin-converting enzyme activity in serum. Clin Chem 1981; 27:1922-25
27. Woolson RF. Statistical methods for the analysis of biomedical data. New York: John Wiley and Sons, 1987
28. Paul M, O'Byrne MB. Airway inflammation and airway hyperresponsiveness. Chest 1986; 90:575-77
29. Erdos EG. Angiotensin I converting enzyme and the change in our concepts through the years. Hypertension 1990; 16: 363-70
30. Smith CWJ, Porro EB, Patton JG, et al. Scanning from an independently specified branch point defines the 3′ splice site of mammalian intron. Nature 1989; 342:243-47